# PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)

> **NCT04854213** · NA · RECRUITING · sponsor: **National Cancer Institute, Naples** · enrollment: 25 (estimated)

## Conditions studied

- Colorectal Cancer Metastatic

## Interventions

- **DEVICE:** Stereotactic Body Radiation Therapy (SBRT)

## Key facts

- **NCT ID:** NCT04854213
- **Lead sponsor:** National Cancer Institute, Naples
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-06
- **Primary completion:** 2025-01
- **Final completion:** 2025-03
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04854213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04854213, "PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04854213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*